DCTH Stock Summary and Trading Ideas (Delcath Systems | NASDAQ:DCTH)

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Systems trades on the NASDAQ stock market under the symbol DCTH.

As of April 6, 2026, DCTH stock price climbed to $9.74 with 108,086 million shares trading.

DCTH has a beta of 1.22, meaning it tends to be more sensitive to market movements. DCTH has a correlation of 0.19 to the broad based SPY ETF.

DCTH has a market cap of $337.98 million. This is considered a Small Cap stock.

Last quarter Delcath Systems reported $21 million in Revenue and -$.05 earnings per share. This beat revenue expectation by $47,250 and missed earnings estimates by -$.01.

In the last 3 years, DCTH traded as high as $18.23 and as low as $2.25.

The top ETF exchange traded funds that DCTH belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

DCTH has underperformed the market in the last year with a return of -25.0%, while SPY returned +17.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in DCTH shares. However, DCTH has outperformed the market in the last 3 month and 2 week periods, returning -2.1% and +4.3%, while SPY returned -3.5% and +0.1%, respectively. This indicates DCTH has been having a stronger performance recently.

DCTH support price is $9.37 and resistance is $9.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DCTH shares will trade within this expected range on the day.